Swiss drugmaker Novartis (NOVN.S) said on Saturday it had received a binding offer from Germany's Siemens Healthineers (SHLG.DE) to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,